Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest announcement is out from TC Biopharm (Holdings) Plc Sponsored ADR ( (TCBP) ).
TC BioPharm (Holdings) Plc has filed a prospectus supplement that will allow the company to offer and sell up to 11.2 billion ordinary shares in the form of American Depositary Shares (ADS). This move is part of an At the Market Offering Agreement with H.C. Wainwright & Co. LLC, intended to provide the company with capital for its operations. The company’s legal counsel has confirmed the validity of this issuance under Scottish law, suggesting a strategic step to strengthen its financial position and enhance its growth prospects.
More about TC Biopharm (Holdings) Plc Sponsored ADR
TC BioPharm (Holdings) Plc operates in the biotechnology industry, focusing on the development and commercialization of cell-based therapies. The company is primarily engaged in the production of innovative therapeutic products targeting various diseases, leveraging its unique technologies in the field of immunotherapy.
YTD Price Performance: -98.27%
Average Trading Volume: 1,168,006
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $271.9K
See more insights into TCBP stock on TipRanks’ Stock Analysis page.
